Oppenheimer Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$149M Sell
610,825
-17,372
-3% -$4.05M 1.7% 5
2025
Q4
$130M Sell
628,197
-22,138
-3% -$4.38M 1.6% 6
2025
Q3
$121M Sell
650,335
-8,918
-1% -$1.53M 1.33% 7
2025
Q2
$101M Buy
659,253
+2,488
+0.4% +$382K 1.15% 9
2025
Q1
$109M Buy
656,765
+76,201
+13% +$11.9M 1.35% 8
2024
Q4
$84M Buy
580,564
+4,620
+0.8% +$716K 1.02% 14
2024
Q3
$93.3M Buy
575,944
+2,040
+0.4% +$325K 1.12% 10
2024
Q2
$83.9M Buy
573,904
+82,787
+17% +$12.3M 1.07% 14
2024
Q1
$77.7M Buy
491,117
+6,481
+1% +$1.03M 1.14% 11
2023
Q4
$76M Sell
484,636
-20,644
-4% -$3.17M 1.06% 11
2023
Q3
$78.7M Sell
505,280
-12,177
-2% -$2.01M 1.21% 7
2023
Q2
$85.6M Sell
517,457
-17,191
-3% -$2.77M 1.26% 7
2023
Q1
$82.9M Buy
534,648
+18,358
+4% +$2.96M 1.28% 6
2022
Q4
$91.2M Sell
516,290
-7,143
-1% -$1.23M 1.47% 5
2022
Q3
$85.5M Buy
523,433
+34,893
+7% +$5.9M 1.51% 5
2022
Q2
$86.7M Buy
488,540
+2,762
+0.6% +$492K 1.45% 6
2022
Q1
$86.1M Buy
485,778
+38,708
+9% +$6.59M 1.22% 8
2021
Q4
$76.5M Buy
447,070
+473
+0.1% +$77.4K 1.01% 12
2021
Q3
$72.1M Buy
446,597
+8,056
+2% +$1.37M 1.03% 12
2021
Q2
$72.2M Buy
438,541
+8,743
+2% +$1.45M 1.03% 10
2021
Q1
$70.6M Buy
429,798
+6,159
+1% +$997K 1.09% 9
2020
Q4
$66.7M Sell
423,639
-16,044
-4% -$2.37M 1.11% 7
2020
Q3
$65.5M Sell
439,683
-12,508
-3% -$1.85M 1.27% 6
2020
Q2
$63.6M Sell
452,191
-14,282
-3% -$2.08M 1.31% 5
2020
Q1
$61.2M Buy
466,473
+2,015
+0.4% +$286K 1.5% 4
2019
Q4
$67.8M Buy
464,458
+1,996
+0.4% +$271K 1.43% 5
2019
Q3
$59.8M Sell
462,462
-9,632
-2% -$1.27M 1.33% 5
2019
Q2
$65.8M Sell
472,094
-9,267
-2% -$1.28M 1.45% 5
2019
Q1
$67.3M Sell
481,361
-9,144
-2% -$1.22M 1.51% 4
2018
Q4
$63.3M Sell
490,505
-5,023
-1% -$701K 1.57% 4
2018
Q3
$68.5M Sell
495,528
-6,200
-1% -$824K 1.52% 4
2018
Q2
$60.9M Sell
501,728
-13,813
-3% -$1.72M 1.49% 3
2018
Q1
$66.1M Sell
515,541
-9,543
-2% -$1.29M 1.66% 3
2017
Q4
$68.3M Hold
525,084
1.81% 2
2017
Q3
$68.3M Buy
525,084
+3,896
+0.7% +$516K 1.77% 2
2017
Q2
$68.9M Sell
521,188
-5,486
-1% -$700K 1.9% 2
2017
Q1
$65.6M Buy
+526,674
New +$62.9M 1.87% 2

Other funds holding JNJ

Oppenheimer Asset Management's JNJ Position: Q1 2026 in Review

Oppenheimer Asset Management reduced its Johnson & Johnson (JNJ) stake by 2.8% in Q1 2026, selling an estimated $4.05M and leaving 610,825 shares worth $149M. The position accounts for 1.7% of the portfolio, ranked #5.

Oppenheimer Asset Management first reported a position in JNJ in Q1 2017 and has held it in 37 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Oppenheimer Asset Management held 610,825 shares of Johnson & Johnson worth $149M as of Q1 2026.
  • Oppenheimer Asset Management sold 17,372 Johnson & Johnson shares in Q1 2026, an estimated $4.05M.
  • Johnson & Johnson made up 1.7% of Oppenheimer Asset Management's portfolio in Q1 2026, its #5 holding.
  • Oppenheimer Asset Management first reported a position in Johnson & Johnson in Q1 2017 and has held it in 37 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Oppenheimer Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.